Literature DB >> 1081893

Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase.

P S Sarin, P N Anderson, R C Gallo.   

Abstract

Terminal deoxynucleotidyl transferase, an enzyme which catalyzes the polymerization of deoxyribonucleoside triphosphates, elongating oligo- or polydeoxynucleotide chains, but without direction from a nucleic acid template, is thought to be specific for thymus gland and thymus-derived cells. We have confirmed the observations that high levels are characteristic of thymus gland with both human and calf tissue and that elevated levels may be found in some cases of acute lymphocytic leukemia. High levels were also found in human lymphoblast cell lines with T-cell characteristics, and insignificant activity was observed in leukocytes of patients with chronic myelogenous leukemia not in acute blast phase of the disease, chronic lymphocytic leukemia, human B-cells, and normal human blood lymphocytes even after stimulation with phytohemagglutinin. However, high levels (approximately 200 nmoles/hr/10(9) cells) equivalent to those in thymus tissue and lymphoblast cell lines with T-cell characteristics were found in the peripheral blood blast cells of four patients with chronic myelogenous leukemia in an acute blast phase of their disease. One hypothesis that may explain the present results is that in chronic myelogenous leukemia in acute blast phase of the disease the proliferative blast response may not always be myeloblasts but in some cases it may be lymphoblasts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1081893

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Lymphoid blast crisis in chronic myeloid leukaemia.

Authors: 
Journal:  Br Med J       Date:  1977-11-19

Review 2.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

3.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.

Authors:  P J Fialkow; A M Denman; R J Jacobson; M N Lowenthal
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

4.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

5.  T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

Authors:  H R Toben; R G Smith
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

6.  Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan.

Authors:  V S Kalyanaraman; M G Sarngadharan; Y Nakao; Y Ito; T Aoki; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Intracellular distribution of terminal deoxynucleotidyl transferase in rat bone marrow and thymus.

Authors:  K E Gregoire; I Goldschneider; R W Barton; F J Bollum
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; S Watanabe; T Masaoka; K Takatsuki; M Kishihara; N Kobayashi; M Hattori; T Fujita
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

9.  Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.

Authors:  S Suciu; E Marinca; F Bornuz; M Crisan; L Petrov; E Rădulescu
Journal:  Blut       Date:  1984-10

10.  A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.

Authors:  M J Modak; R Mertelsmann; B Koziner; R Pahwa; M A Moore; B D Clarkson; R A Good
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.